Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4250032

CC1(N)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.38
SLC1A2 P43004 2/20 0.35
ALDH1A1 P00352 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
DGAT1 O75907 1/20 0.33
F2 P00734 1/20 0.33
F11 P03951 1/20 0.33
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
PRSS3 P35030 1/20 0.33
CPB2 Q96IY4 6/20 0.32
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
BACE1 P56817 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4252856 0.93 CPB2 (0.36) FFAR3SLC1A2ALDH1A1TDP1DGAT1
Trifluoroacetic Acid SCHEMBL3558294 0.91 CPB2 (0.38) FFAR3SLC1A2ALDH1A1F2F11
Trifluoroacetic Acid SCHEMBL22191335 0.85 ALDH1A1 (0.39) SLC1A2ALDH1A1TDP1F2F11
Trifluoroacetic Acid SCHEMBL867165 0.80 SLC1A2 (0.31) SLC1A2
Trifluoroacetic Acid SCHEMBL4247792 0.78 SLC1A2 (0.36) SLC1A2ALDH1A1TDP1F2F11
Oxalic Acid SCHEMBL3401579 0.77 FFAR3 (0.45) FFAR3SLC1A2ALDH1A1TDP1TSHR
Trifluoroacetic Acid SCHEMBL29615579 0.76 ALDH1A1 (0.41) FFAR3ALDH1A1F2F11PRSS1
Trifluoroacetic Acid SCHEMBL1731636 0.76
Trifluoroacetic Acid SCHEMBL30132310 0.76
Trifluoroacetic Acid SCHEMBL20974146 0.76 SLC1A2 (0.33) SLC1A2ALDH1A1DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11555042-B2 Macrocyclic compounds as TRK kinases inhibitors FOCHON BIOSCIENCES, LTD. (CN) 2023-01-17 US disclosed
US-8188084-B2 Pyridinone and pyridazinone derivatives as inhibitors of poly (ADP-ribose) polymerase (PARP) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA. (IT) 2012-05-29 US disclosed
US-20090176765-A1 Pyridinone and Pyridazinone Derivatives as Inhibitors of Poly (Adp-Ribose) Polymerase (Parp) MSD ITALIA S.R.L. (IT) 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11555042-B2 Macrocyclic compounds as TRK kinases inhibitors PLK2, ERBB3, DMPK FFAR3 1417/4885SLC1A2 4698/4885ALDH1A1 4722/4885
US-20090176765-A1 Pyridinone and Pyridazinone Derivatives as Inhibitors of Poly (Adp-Ribose) Polymerase (Parp) PARP1, PARP2, PARP3 FFAR3 2866/4885SLC1A2 4508/4885ALDH1A1 278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.